Concord Drugs Q2 Results
- BSE: 538965
- NSE: -
- ISIN: INE858L01010
- Sector: Biotechnology & Drugs
BSE
34.75
-1.25 (-3.47%)
-1.25 (-3.47%)Volume12.68 K
Updated: Tue 26 Nov, 2024 | 15:29:55
NSE
This stock is not traded on NSE
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q2 Results Highlights
- Total Income₹12.36 Cr.(5.71%)
- Operating Profit₹0.52 Cr.(5.73%)
- Profit After Tax₹0.04 Cr.(59.56%)
- Operating Margin4.22%(-73.91%)
Note: Comparison is on YoY basis
Quarterly - Concord Drugs Q2 Results
*All figures in crores except per share values
| Fiscal Period | Sep 24 | Jun 23 | QoQ Comp | Sep 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Revenue | 12.36 | 8.98 | -% | 7.52 | -% |
| Selling/ General/ Admin Expenses Total | 0.93 | 1.38 | -% | 1.46 | -% |
| Depreciation/ Amortization | 0.34 | 0.38 | -% | 0.39 | -% |
| Other Operating Expenses Total | 0.41 | 0.35 | -% | 0.36 | -% |
| Total Operating Expense | 11.84 | 7.91 | -% | 6.30 | -% |
| Operating Income | 0.52 | 1.08 | -% | 1.22 | -% |
| Net Income Before Taxes | 0.07 | 0.64 | -% | 0.80 | -% |
| Net Income | 0.04 | 0.49 | -% | 0.56 | -% |
| Diluted Normalized EPS | 0.04 | 0.53 | -% | 0.60 | -% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
- Markets
01NTPC Green Energy IPO allotment status out. GMP, how to check status online
2 min read06:38 AM IST - Markets
02Enviro Infra Engineers IPO day 3: GMP rises after strong subscription status. Apply or not?
3 min read03:38 PM IST - Markets
03Stock market today: Trade setup for Nifty 50, gold to Russia-Ukraine war; 5 stocks to buy or sell on Tuesday — Nov 26
5 min read06:44 AM IST